Discover the latest breakthroughs in multiple myeloma treatment, including CAR T-cell therapies and promising new options for ...

Patients share their experiences with myeloma, discussing the impact on physical activities and the importance of maintaining ...

Estimates based on the most recent data from the NCI's Surveillance, Epidemiology, and End Results (SEER) program show that ...

Experts discuss the evolving role of bispecific antibodies in multiple myeloma, highlighting treatment advancements and strategies for optimal patient care.

Experts discuss the critical challenges in accessing innovative treatments for relapsed refractory multiple myeloma, emphasizing equity and education.

Findings from a study on the role of exosomal non-coding RNAs (ncRNAs) in the progression of multiple myeloma (MM), with a specific focus on sex-based differences, show that while male and female ...

To Jagannath, cure means long periods of disease-free survival as defined by minimal residual disease (MRD) criteria, 10 -5 ...

Multiple myeloma – a rare form of blood cancer – is usually found in people 65 and older. While it’s rare in young adults, a small percentage of people 19-40 also have the disease. Only 10% of people ...

Hip-hop and storytelling can enhance health communication, making messages resonate more authentically with underserved ...

Fred Hutch Cancer Center is at the forefront of research and developing new treatments for multiple myeloma. Our researchers pioneered blood and marrow transplant (BMT), which is one of the most ...

If your doctor tells you that you're having a relapse, it means your multiple myeloma came back after your treatment left you cancer-free for a while. If this happens to you, keep in mind that there ...